Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health & Wellness Today New York.
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
GlobeNewswire, Inc.
·
July 11, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the...
New York Festivals Advertising Awards and Lightricks LTX Studio Announce the 2025 NYFAi Competition Award Winners
EIN Presswire
·
July 10, 2025
CYLNDR Studios Earns Gold, Clutch Takes Silver, and Code and Theory receives Bronze NEW YORK, NY, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- New York Festivals Advertising Awards (NYFA) announced the winners of the inaugural NYFAi...
Gramercy Physical Therapy Expands One-on-One Manual Therapy and Custom Orthotics Services in NYC
EIN Presswire
·
July 10, 2025
Gramercy PT enhances personalized rehab in NYC with expanded manual therapy, custom orthotics, and AFO fittings for patients with neurological gait issues. NEW YORK, NY, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Gramercy Physical...
Shareholders that lost money on Petco Health and Wellness Company, Inc. (WOOF) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF). Shareholders who purchased shares of WOOF during the class period listed are...
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join – Contact The Gross Law Firm
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive...
New York State Society of CPAs Launches New Financial Leadership Certificate Program: Accounting & Review Series
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- The New York State Society of Certified Public Accountants (NYCPA) and the Foundation of Accounting Education (FAE) are pleased to announce the launch of their Financial Leadership Certification Program:...
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers”...
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or...
CAHME Announces the Reaccreditation of the Stony Brook University Program in Public Health’s MHA Program.
EIN Presswire
·
July 10, 2025
CAHME Board of Directors approved the reaccreditation of Stony Brook University, MHA for an eight-year term. SPRING HOUSE, PA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- The Commission on Accreditation of Healthcare Management Education...
From Tech-Driven Health to Herbal Healing: What’s New in Wellness This Season
EIN Presswire
·
July 10, 2025
NEW YORK, NY, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- With more travelers planning trips around overall wellbeing and natural healing new spa openings are focusing less on pampering and more on restoring the body through nature,...
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire, Inc.
·
July 10, 2025
DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life,...
Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
GlobeNewswire, Inc.
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Interleukin-2 (IL-2) inhibitors are immunosuppressive...
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire, Inc.
·
July 10, 2025
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining...
Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health...
Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers – WOOF
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) and certain officers. The class action, filed...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
GlobeNewswire, Inc.
·
July 10, 2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton...